Hyresintäkterna steg med 38% till 12,4 meur och förvaltningsresultat ökade med 37% till 6,2 meur på ...
Finnair reports Q4 results on Feb 13. Q4 traffic data was mostly encouraging even if European routes...
F&MT initiates cost-cutting program Gradual recovery expected Q4 due on 10 February Q4e: Organic sa...
On February 4thth, Eevia Health Plc (publ) (“Eevia”) announced that the Company has agreed to sell I...
Redeye’s first comments follow this morning’s Q4 report from Tagmaster.
Redeye comments on the Q4 report released earlier this morning.
Redeye returns with a more in-depth take on OssDsign’s Q4 report.
Redeye maintains its fair value range for Sleep Cycle following the Q4 2024 report, which met our sa...
Sales and gross margin above expectations in Q4 EBIT revised up by 2.
Kingspan bids SEK 182.5/shareNWG's board recommends accepting the bidHighly likely the bid will go t...
Redeye sees another strong quarter for OssDsign as sales beat our estimates with a continuing robust...
Raute reports Q4 results on Feb 13. FY’24 already showed strong results, while low valuation limits ...
Beat in Q4 driven by higher sales EBIT +7% vs ABGSCe Estimates likely to be revised up 2-5% on EBIT ...
Redeye is encouraged by the healthy rebound in demand witnessed in Ependion’s Q4 report.
Ahead of Taaleri's Q4 results, we revise our underlying estimates to reflect Taaleri's sale of its s...
